ES8603442A1 - Procedimiento para la obtencion de derivados piperazinicos - Google Patents

Procedimiento para la obtencion de derivados piperazinicos

Info

Publication number
ES8603442A1
ES8603442A1 ES542946A ES542946A ES8603442A1 ES 8603442 A1 ES8603442 A1 ES 8603442A1 ES 542946 A ES542946 A ES 542946A ES 542946 A ES542946 A ES 542946A ES 8603442 A1 ES8603442 A1 ES 8603442A1
Authority
ES
Spain
Prior art keywords
opt
alkyl
substd
aryl
unsatd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542946A
Other languages
English (en)
Other versions
ES542946A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Selvi and C SpA
Original Assignee
Selvi and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selvi and C SpA filed Critical Selvi and C SpA
Publication of ES8603442A1 publication Critical patent/ES8603442A1/es
Publication of ES542946A0 publication Critical patent/ES542946A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS PIPERAZINICOS, ASI COMO DE SUS ENANTIOMEROS Y DIASTEREOISOMEROS, DE FORMULA (I), EN LA QUE Y, A, R, R1, R2, R3 Y R4 PUEDEN SER VARIOS TIPOS DE RADICALES; X REPRESENTA HALOGENO O EL ANION DE UN ACIDO; Y N VALE 0-3. CONSISTE EN LA REDUCCION DEL GRUPO CARBONILO A GRUPO CH2 EN UNA AMIDA DE FORMULA (II), EN LA QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REDUCCION SE LLEVA A CABO CON UN HIDRURO METALICO, TAL COMO HIDRURO DE LITIO Y ALUMINIO, EN UN DISOLVENTE INERTE, TAL COMO TETRAHIDROFURANO, A LA TEMPERATURA AMBIENTE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SUS EFECTOS ESPASMOLITICOS ANTICOLINERGICOS.
ES542946A 1982-09-27 1985-04-16 Procedimiento para la obtencion de derivados piperazinicos Granted ES542946A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/424,512 US4457931A (en) 1982-09-27 1982-09-27 Piperazine derivatives with anticholinergic and/or antihistaminic activity

Publications (2)

Publication Number Publication Date
ES8603442A1 true ES8603442A1 (es) 1986-01-01
ES542946A0 ES542946A0 (es) 1986-01-01

Family

ID=23682887

Family Applications (3)

Application Number Title Priority Date Filing Date
ES525953A Expired ES8604543A1 (es) 1982-09-27 1983-09-26 Procedimiento para la obtencion de derivados piperazinicos
ES542946A Granted ES542946A0 (es) 1982-09-27 1985-04-16 Procedimiento para la obtencion de derivados piperazinicos
ES542947A Granted ES542947A0 (es) 1982-09-27 1985-04-16 Procedimiento para la obtencion de derivados piperazinicos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES525953A Expired ES8604543A1 (es) 1982-09-27 1983-09-26 Procedimiento para la obtencion de derivados piperazinicos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES542947A Granted ES542947A0 (es) 1982-09-27 1985-04-16 Procedimiento para la obtencion de derivados piperazinicos

Country Status (10)

Country Link
US (1) US4457931A (es)
JP (1) JPS5989665A (es)
BE (1) BE897828A (es)
DE (1) DE3334757A1 (es)
ES (3) ES8604543A1 (es)
FR (1) FR2533564B1 (es)
GB (1) GB2135991B (es)
IT (1) IT1212088B (es)
NL (1) NL8303311A (es)
ZA (1) ZA836949B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147466A (ja) * 1984-08-10 1986-03-07 Dainippon Pharmaceut Co Ltd アミン誘導体
FR2573075B1 (fr) * 1984-09-14 1987-03-20 Innothera Lab Sa Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
GB2227018B (en) * 1989-01-13 1992-05-20 Wyeth John & Brother Ltd Piperazinylalkylcarboxylic acid adamantylamides
JPH05255089A (ja) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
SE9201956D0 (sv) * 1992-06-25 1992-06-25 Kabi Pharmacia Ab Novel nicotinicacid esters
GB9817197D0 (en) * 1998-08-07 1998-10-07 Lilly Co Eli Pharmaceutical compounds
ATE449090T1 (de) * 2001-07-02 2009-12-15 High Point Pharmaceuticals Llc Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
AU2004265243A1 (en) * 2003-06-20 2005-02-24 Arena Pharmaceuticals, Inc. N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5HT2c receptor associated diseases
EP1670314A4 (en) * 2003-09-05 2009-02-25 Sequella Inc METHODS AND COMPOSITIONS INCLUDE DIAMINE AS A NEW THERAPEUTIC FOR TUBERCULOSIS
TW200633721A (en) * 2004-12-14 2006-10-01 Shionogi & Co A pharmaceutical composition for treating constipation
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR997607A (fr) * 1949-10-14 1952-01-08 American Cyanamid Co Perfectionnements relatifs aux pipérazines substituées
US2794804A (en) * 1955-03-24 1957-06-04 American Cyanamid Co Substituted piperazines and method of preparing the same
NL297170A (es) * 1963-04-04 1900-01-01
US3712893A (en) * 1969-11-10 1973-01-23 Cerm Cent Europ Rech Mauvernay Butyl-piperazine derivatives
JPS49101383A (es) * 1973-02-05 1974-09-25
JPS517673A (ja) * 1974-07-08 1976-01-22 Hitachi Ltd Hansoshisutemu
JPS5111635A (es) * 1974-07-18 1976-01-29 Hideji Kitamura
FR2306694A1 (fr) * 1975-04-07 1976-11-05 Parcor Derives de la piperazine
JPS523387A (en) * 1975-06-24 1977-01-11 Nec Home Electronics Ltd Manufacturing method of semiconductor device
JPS54103893A (en) * 1978-01-26 1979-08-15 Morishita Pharma 1*44benzodioxane derivative
AU532411B2 (en) * 1979-03-01 1983-09-29 Duphar International Research B.V. Phenyl piperazine derivatives
JPS5827793B2 (ja) * 1980-09-18 1983-06-11 住友化学工業株式会社 新規なアニリン誘導体の製法
JPS5761149A (en) * 1980-09-30 1982-04-13 Matsushita Electric Works Ltd Staircase

Also Published As

Publication number Publication date
ES8603443A1 (es) 1986-01-01
FR2533564A1 (fr) 1984-03-30
ZA836949B (en) 1984-05-30
ES525953A0 (es) 1986-02-01
JPS5989665A (ja) 1984-05-23
ES542947A0 (es) 1986-01-01
GB2135991B (en) 1985-12-04
NL8303311A (nl) 1984-04-16
FR2533564B1 (fr) 1986-10-03
GB2135991A (en) 1984-09-12
IT8322784A0 (it) 1983-09-06
DE3334757A1 (de) 1984-03-29
GB8325839D0 (en) 1983-10-26
IT1212088B (it) 1989-11-08
ES542946A0 (es) 1986-01-01
JPS6139289B2 (es) 1986-09-03
ES8604543A1 (es) 1986-02-01
BE897828A (nl) 1984-01-16
US4457931A (en) 1984-07-03

Similar Documents

Publication Publication Date Title
ES8603443A1 (es) Procedimiento para la obtencion de derivados piperazinicos
FI831604L (fi) Pyridinderivat, deras framstaellning och anvaendning
DE69321525D1 (de) Morphinan-derivate und medizinische verwendung
EP0264795A3 (de) Aminosäurederivate
FI900613A0 (fi) Menetelmä farmakologisesti aktiivisten heterosyklisten yhdisteiden valmistamiseksi
ES8507104A1 (es) Un metodo para producir un derivado de amina
GB1435139A (en) Thiazole derivatives
ES8307775A1 (es) Un procedimiento para la preparacion de una sal cristalina, no higroscopica y soluble en agua de etilendiamina, monoetanolamina o dietanolamina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida.
ES8707211A1 (es) Un procedimiento para la preparacion de derivados de dioxido de benzotiazina
ZA839382B (en) New substituted 1,4-dihydropyridines,process for their preparation and their use as medicaments
ES8800240A1 (es) Un metodo para preparar derivados de cefem
NO167291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemforbindelser.
DK540684A (da) Benzoquinoliziner
SE8406338D0 (sv) 4,5,6,7-tetrahydrotiazolo/5,4-c/-pyridinderivat
ATE135576T1 (de) Anxiolytisch wirksame piperazinderivate
DK0461574T3 (da) Lægemidler indeholdende 3,7-diazabicyclo(3,3,1)-nonanforbindelser
ATE3542T1 (de) Als heilmittel verwendbare alcoxypropanolamine und verfahren zu ihrer herstellung.
EP0011092B1 (en) Alpha-aminophenylacetic acid derivatives for use in the treatment of inflammations and novel alpha-aminophenylacetic acid derivatives
OA07703A (fr) Polyméthylène imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
ES416614A1 (es) Procedimiento de preparacion de (benzoil-2et-1'-il)-1-(ci- namil-4''-piperazin-1''-il-metil)-2-bencimidazoles.
ES547603A0 (es) Un procedimiento para preparar derivados de piridina
SE8004498L (sv) Pyridylaminotriazolderivat
FR2231372A1 (en) 2-(3-Aminopropionyl)-benzofuran compns. - for treating spasm and as inhibitors of biosynthesis of uric acid
FR2073427A1 (en) 4-methyl-5-ethyl-n-heterocyclic thiazoles - with antianoxic activity
DK347379A (da) Pyrano-heterocycler fremgangsmaader til fremstilling deraf og laegemidler indeholdende disse forbindelser

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401